OTC: ERFSF - Eurofins Scientific SE

Yield per half year: +2.08%
Sector: Healthcare

Eurofins Scientific SE

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
4/10
38.13 31.94 19.38% 35.3 +8.03%
P/S 1.82 3.27 -44.48%
P/BV 3.16 3.37 -6.26%
P/FCF 26.92 21.19 27.03%
Ev/Ebitda 12.89 10.05 28.24%
Ev/S 2.4 1.91 25.38%
Ev/FCF 39.29 20.45 92.09%
E/P 0.029 1.47 -98.02%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
6/10
18.59 24.26 -23.35% 21.39 -13.07%
ROE 8.41 13.23 -36.43%
ROA 3.15 6.16 -48.87%
ROIC 0 15.56 -100%
ROS 4.76 12.56 -62.1%
ROCE 14.58 14.33 1.77%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
5/10
2.61 6.16 -57.67% 2.44 +7.03%
Nеt Debt/Ebitda 3.12 -5.78 -153.94%
Debt/Ratio 0.3204 0.2073 54.58%
Debt/Equity 1.39 12.5 -88.89%
Debt/Net Income 10.18 14.94 -31.86%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
5.6/10
2.24 1.76 27.31% 1.19 +87.7%
Number of years of dividend growth 1 1.27 -21.11%
DSI 0.8571 0.7783 10.13%
Average dividend growth 6.18 -270.03 -102.29%
Average percentage for 5 years 1.19 2.79 -57.3%
Average percentage for payments 18.85 246.75 -92.36%
Difference from average difference in sector 0.4805

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
7/10
52 140.59 -63.01%
Growth impulse Ebitda in 5 years 58.59 106.87 -45.18%
Growth impulse Net Income in 5 years 69.06 123.16 -43.93%
Growth impulse FCF in 5 years 96.79 93.7 3.3%
Growth impulse EPS in 5 years 60.19 239.27 -74.84%
IP Score
5.44/10

Similar companies

Chugai Pharmaceutical Co., Ltd.

Sinopharm Group Co., Ltd.

Roche Holding

Sinopharm Group Co., Ltd.

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription